Tiny carrier can help treat brain tumour

Image
IANS New York
Last Updated : May 22 2016 | 2:28 PM IST

A nanocarrier engineered to be small enough to get past the blood-brain barrier could be targeted to deliver a chemotherapeutic drug more efficiently to tumour cells in the brain, a new study reveals.

The blood-brain barrier is a protective barrier designed to keep a stable environment within and surrounding the brain. In experiments, the researchers found that the new method resulted in increased killing in the targeted cells.

"I was very surprised by how efficiently and well it worked once we got the nanocarrier to those cells," said Ann-Marie Broome from Medical University of South Carolina in the US.

The findings potentially point the way to a new treatment option for patients with certain conditions, such as glioblastoma multiforme (GBM), the focus of this study.

Glioblastoma multiforme is a devastating disease with no curative options due to several challenges, Broome said.

The brain tumour has a significant overall mortality, in part due to its location, difficulty of surgical treatment and the inability to get drugs through the blood-brain barrier.

In 40 percent of cases, standard treatments will extend life expectancy four to seven months.

That led the researchers engineer a micelle that is a phospholipid nanocarrier, "a bit of fat globule," to deliver a concentrated dose of the chemotherapy drug temozolomide (TMZ) to the deadly tumour cells.

"Micelles of a certain size will cross the blood-brain barrier carrying a concentrated amount of TMZ," Broome explained about how the nanotechnology works.

The study was published online in the international journal Nanomedicine - Future Medicine.

In medicine, Broome said, researchers construct nanocarriers that are stable and stealthy. "Your immune cells can't attack them. They remain hidden.

"When the package gets to where it's going, nanotechnologists have various methods to get the micelles to release their payloads -- one way is to use the acidic nature of a rapidly growing tumour," she said.

--IANS

gb/ksk/vt

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: May 22 2016 | 2:22 PM IST

Next Story